In Advisory Opinion 20-02, the Office of Inspector General (OIG) approved certain lodging and travel assistance offered by a pharmaceutical manufacturer to patients being administered a drug manufactured by the pharmaceutical...more
2/29/2020
/ Advisory Opinions ,
Anti-Kickback Statute ,
Beneficiary Inducement ,
Black Box Warnings ,
Civil Monetary Penalty ,
Food and Drug Administration (FDA) ,
Free Health-Related Services ,
Medical Reimbursement ,
OIG ,
Patient Assistance Programs ,
Patients ,
Personalized Medicine ,
Pharmaceutical Industry ,
Prescription Drugs ,
REMS
In Advisory Opinion 19-03, the Office of Inspector General (OIG) approved a program proposed by a medical center that has been providing free, in-home follow-up care to eligible individuals with congestive heart failure...more
The growing concern over opioid abuse has prompted both the federal government and many states to address concerns over referrals for substance abuse treatment. Tennessee recently addressed the issue in House Bill No. 2068,...more
10/30/2018
/ Anti-Kickback Statute ,
Civil Monetary Penalty ,
Drug & Alcohol Abuse ,
Drug Treatment ,
False Statements ,
Health Care Providers ,
Hospitals ,
Marketing ,
New Legislation ,
Opioid ,
Patient Referrals ,
State and Local Government ,
Substance Abuse